clinical trial · NCT06425003
Study of [14C] ABBV-CLS-7262 in Healthy Male Volunteers Following Single Oral Dose Administration
Healthy Volunteer[14C] ABBV-CLS-7262
brief summary
The purpose of this study is to evaluate mass balance, pharmacokinetics and safety of \[14C\] ABBV-CLS-7262 in healthy, male volunteers following administration of a single oral dose.
started
May 21, 2024
primary completion
Jul 12, 2024
completion
Jul 12, 2024
last updated
Jul 19, 2024
official title
Mass Balance Study of [14C] ABBV-CLS-7262 in Healthy Male Volunteers Following Single Oral Dose Administration
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol